290 related articles for article (PubMed ID: 30537427)
1. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
Zeng QY; Xia ZY; Tong YS; Sun L; Mou HB; Chen R; Bi GY; Liu CH
Nephrology (Carlton); 2019 Oct; 24(10):1001-1008. PubMed ID: 30537427
[TBL] [Abstract][Full Text] [Related]
2. The association of the Klotho polymorphism rs9536314 with parameters of calcium-phosphate metabolism in patients on long-term hemodialysis.
Marchelek-Myśliwiec M; Różański J; Ogrodowczyk A; Dutkiewicz G; Dołęgowska B; Sałata D; Budkowska M; Safranow K; Stępniewska J; Wiśniewska M; Ciechanowski K
Ren Fail; 2016 Jun; 38(5):776-80. PubMed ID: 27055909
[TBL] [Abstract][Full Text] [Related]
3. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
4. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
Sawires HK; Essam RM; Morgan MF; Mahmoud RA
Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
[TBL] [Abstract][Full Text] [Related]
5. Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis.
Elghoroury EA; Fadel FI; Elshamaa MF; Kandil D; Salah DM; El-Sonbaty MM; Farouk H; Raafat M; Nasr S
Pediatr Nephrol; 2018 Jun; 33(6):1019-1027. PubMed ID: 29313136
[TBL] [Abstract][Full Text] [Related]
6. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
Sakan H; Nakatani K; Asai O; Imura A; Tanaka T; Yoshimoto S; Iwamoto N; Kurumatani N; Iwano M; Nabeshima Y; Konishi N; Saito Y
PLoS One; 2014; 9(1):e86301. PubMed ID: 24466013
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.
Mercadal L; Tezenas du Montcel S; Chonchol MB; Debure A; Depreneuf H; Servais A; Bassilios N; Assogba U; Allouache M; Prié D
Am J Nephrol; 2018; 48(5):349-356. PubMed ID: 30408788
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
[TBL] [Abstract][Full Text] [Related]
9. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
[TBL] [Abstract][Full Text] [Related]
10. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
[TBL] [Abstract][Full Text] [Related]
11. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression.
Rutkowski JM; Pastor J; Sun K; Park SK; Bobulescu IA; Chen CT; Moe OW; Scherer PE
Kidney Int; 2017 Feb; 91(2):324-337. PubMed ID: 27914707
[TBL] [Abstract][Full Text] [Related]
13. [Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis].
Nabeshima Y
Clin Calcium; 2008 Jul; 18(7):923-34. PubMed ID: 18591743
[TBL] [Abstract][Full Text] [Related]
14. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
16. Klotho expression in long bones regulates FGF23 production during renal failure.
Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
[TBL] [Abstract][Full Text] [Related]
17. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.
Razzaque MS
Nat Rev Endocrinol; 2009 Nov; 5(11):611-9. PubMed ID: 19844248
[TBL] [Abstract][Full Text] [Related]
18. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
[TBL] [Abstract][Full Text] [Related]
20. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
